Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04142619 |
| Title | Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Cellectis S.A. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSF Medical Center- Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94115 | United States | Details | |
| Sarah Cannon Research Institute - Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| Winship Cancer Institute Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| Mayo Clinical Cancer Center (MCCC) | Rochester | Minnesota | 55905 | United States | Details | |
| Hackensack Meridian Health | Hackensack | New Jersey | 07601 | United States | Details | |
| Sarah Cannon Research Institute - Tennessee Oncology | Nashville | Tennessee | 37203-1625 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| Sarah Cannon Research Institute - Methodist Healthcare | San Antonio | Texas | 78229-6306 | United States | Details |